These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 12642975

  • 21. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M.
    Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
    [Abstract] [Full Text] [Related]

  • 22. Oral hypoglycemics: increased postoperative mortality in coronary risk patients.
    Jeger RV, Seeberger MD, Keller U, Pfisterer ME, Filipovic M.
    Cardiology; 2007; 107(4):296-301. PubMed ID: 17264509
    [Abstract] [Full Text] [Related]

  • 23. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent).
    Kalsekar I, Sheehan C, Peak A.
    Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874
    [Abstract] [Full Text] [Related]

  • 24. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M, Dellweg S, Osborn C, Heinemann L, Buchwald A, Rosskamp R, Genova P, Heise T.
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [Abstract] [Full Text] [Related]

  • 25. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 26. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
    Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G.
    Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
    [Abstract] [Full Text] [Related]

  • 27. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
    Cheong C, Barner JC, Lawson KA, Johnsrud MT.
    Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
    [Abstract] [Full Text] [Related]

  • 28. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [Abstract] [Full Text] [Related]

  • 29. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
    Hauner H, Kohlmann T, Landgraf W, Holle R, Pirk O, Scholten T.
    Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
    [Abstract] [Full Text] [Related]

  • 30. Cancer risks in thiazolidinedione users compared to other anti-diabetic agents.
    Koro C, Barrett S, Qizilbash N.
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):485-92. PubMed ID: 17192841
    [Abstract] [Full Text] [Related]

  • 31. Health outcomes for diabetes patients returning for three annual general practice checks.
    Tomlin A, Dovey S, Tilyard M.
    N Z Med J; 2007 Apr 13; 120(1252):U2493. PubMed ID: 17460743
    [Abstract] [Full Text] [Related]

  • 32. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
    Simeone JC, Quilliam BJ.
    Ann Pharmacother; 2012 Feb 13; 46(2):157-68. PubMed ID: 22234990
    [Abstract] [Full Text] [Related]

  • 33. [Renewal of oral therapy for diabetes mellitus after secondary failure].
    Guberman D.
    Harefuah; 1989 Nov 01; 117(9):240-1. PubMed ID: 2693275
    [Abstract] [Full Text] [Related]

  • 34. Treating non-insulin-dependent diabetes. Oral agents or insulin?
    Shlossberg AH.
    Can Fam Physician; 1993 Jan 01; 39():119-20, 123-6. PubMed ID: 8435549
    [Abstract] [Full Text] [Related]

  • 35. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes.
    Dezii CM, Kawabata H, Tran M.
    South Med J; 2002 Jan 01; 95(1):68-71. PubMed ID: 11827247
    [Abstract] [Full Text] [Related]

  • 36. Insulin--not always a life sentence: withdrawal of insulin therapy in non-insulin dependent diabetes.
    Cohen M, Crosbie C, Cusworth L, Zimmet P.
    Diabetes Res; 1984 May 01; 1(1):31-4. PubMed ID: 6397285
    [Abstract] [Full Text] [Related]

  • 37. Intensifying treatment of type 2 diabetes mellitus: adding insulin.
    Peters KR.
    Pharmacotherapy; 2011 Dec 01; 31(12 Suppl):54S-64S. PubMed ID: 22122223
    [Abstract] [Full Text] [Related]

  • 38. [Examination of the treatment of elderly type 2 diabetics--is it possible to change from insulin to oral hypoglycemic agents?].
    Oda K.
    Gan To Kagaku Ryoho; 2000 Dec 01; 27 Suppl 3():711-3. PubMed ID: 11190329
    [Abstract] [Full Text] [Related]

  • 39. [Step-wise drug therapy in type 2 diabetes mellitus].
    König K, Schatz H.
    Z Arztl Fortbild Qualitatssich; 1998 Sep 01; 92(7):467-73. PubMed ID: 9842691
    [Abstract] [Full Text] [Related]

  • 40. [Insulin in the treatment of type 2 diabetes].
    Meyer L, Guerci B, Ziegler O, Drouin P.
    Rev Prat; 1999 Jan 01; 49(1):51-5. PubMed ID: 9926717
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.